0000000000215269
AUTHOR
G.f. Draenert
showing 2 related works from this author
Dexrazoxane shows cytoprotective effects in zoledronic acid-treated human cells in vitro and in the rabbit tibia model in vivo
2012
Abstract Introduction Bisphosphonates are important and effective drugs in oncology and osteoporosis therapy. They accumulate in the bone matrix becoming released and active by bone resorption. This leads to effective inhibition of tumor cells and bone degradation. A side effect of bisphosphonates similar to other drugs like denosumab is osteonecrosis of the jaws (ONJ). This problem mostly occurs after tooth extraction. We studied the cytoprotectant dexrazoxane known from anthracycline chemotherapy for cytoprotection in nitrogen-containing bisphosphonate treated cells and in the rabbit tibia model to evaluate a possible value in ONJ management. Materials & methods Human osteoblasts (HOB) P2…
High-density polyethylene facial implants show surface oxidation in SEM and EDX examination: a pilot study.
2009
Previous histopathological studies on explanted Medpor high-density polyethylene (HDPE) facial implants indicated signs of material destruction and claimed to observe phagocytized HDPE particles within the tissue samples beside the usual type IV reaction with severe fibrosis. We examined new and explanted Medpor material with scanning electron microscopy (SEM) and energy-dispersive X-ray analysis (EDX). The implant surface of three patient-derived specimens showed significantly higher oxygenation in EDX analysis and morphological changes in SEM compared to the new unused material directly after opening of the package and after 1 year of exposure to air. Our preliminary findings indicate a p…